Aarey Drugs & Pharmaceuticals Ltd Locks at Lower Circuit With 4.98% Loss — Sellers Queue, No Buyers in Sight

Lower Circuit Event and Unfilled Supply

The stock hit its lower circuit at Rs 86.00, down 4.98% from the previous close, within a 5% price band. This price band capped the maximum daily loss allowed by the exchange, effectively freezing trading at the floor price. The total traded volume was 1.47 lakh shares, with a turnover of Rs 0.13 crore. Despite this turnover, the presence of unfilled supply was evident as sellers continued to queue without buyers stepping in. This scenario is typical for lower circuit events, where supply overwhelms demand to the point that the circuit breaker intervenes, halting further price decline but also trapping sellers who arrived too late to exit. Aarey Drugs & Pharmaceuticals Ltd is now in this precarious position, raising questions about the depth of selling pressure and the potential for further downside.

Delivery and Volume Analysis

Delivery volumes on 29 Apr 2026, the previous trading day, stood at 1.42 lakh shares, which is an 18.95% decline against the 5-day average delivery volume. This fall in delivery volume suggests that the recent selling pressure may be driven more by speculative short-selling rather than genuine liquidation of holdings. On a lower circuit day, rising delivery volumes typically indicate holders are offloading actual positions, signalling capitulation or forced selling. However, in this case, the reduced delivery volume points to a different dynamic — the selling may be less about holders exiting and more about intraday traders or short sellers. Aarey Drugs & Pharmaceuticals Ltd's delivery data thus complicates the interpretation of the lower circuit event, does this suggest the selling pressure is more speculative or is genuine capitulation still a risk?

Intraday Price Action

The intraday range for Aarey Drugs & Pharmaceuticals Ltd was relatively narrow, with a high of Rs 90.00 and a low of Rs 85.99. The stock opened near the higher end of this range but quickly descended to the circuit floor, where it remained locked. This limited intraday swing of approximately 4.5% within the 5% price band indicates that the selling pressure was persistent throughout the session, with no significant recovery attempts. The weighted average price was closer to the low, confirming that most volume traded near the circuit price. This pattern suggests that sellers dominated the session from the outset, and buyers were absent or unwilling to engage at higher levels. does this intraday behaviour point to exhaustion or could further declines be imminent?

Moving Averages and Trend Context

Technically, the stock trades higher than its 20-day, 50-day, 100-day, and 200-day moving averages but remains below the 5-day moving average. This unusual configuration suggests a short-term weakness amid a longer-term base of support. The 5-day moving average acting as resistance indicates recent selling pressure has disrupted the immediate trend, while the longer-term averages may still offer some cushion. However, the lower circuit event confirms that the short-term momentum is negative, and the stock is struggling to find buyers even at these depressed levels. below all moving averages and now locked at lower circuit — does the technical profile of Aarey Drugs & Pharmaceuticals Ltd show any nearby support level, or is the next floor lower still?

Liquidity and Exit Risk for a Micro-Cap

With a market capitalisation of Rs 257 crore, Aarey Drugs & Pharmaceuticals Ltd is classified as a micro-cap stock. Its liquidity profile is modest, with a trade size of approximately Rs 0.05 crore based on 2% of the 5-day average traded value. The total turnover on the circuit day was Rs 0.13 crore, but much of the supply went unfilled due to the circuit lock. This creates a significant exit risk for holders wishing to liquidate sizeable positions, as the lack of buyers at the floor price means sellers may remain trapped for multiple sessions. This liquidity constraint amplifies the impact of the lower circuit, making it harder for investors to exit without further price concessions. with unfilled sell orders at Rs 86.00 and near-zero liquidity, how deep is the exit problem for Aarey Drugs & Pharmaceuticals Ltd and what would need to change for normal trading to resume?

Fundamental Context

Operating within the Pharmaceuticals & Biotechnology sector, Aarey Drugs & Pharmaceuticals Ltd has experienced a consecutive two-day decline, losing 9.65% over this period. The sector itself declined by 0.86% on the day, while the broader Sensex fell 1.00%, indicating that the stock's underperformance is largely stock-specific rather than market-driven. This divergence highlights the particular challenges facing the company’s shares, rather than a general sector or market sell-off.

Conclusion: Severity and Liquidity Caveats

The lower circuit lock at a 4.98% loss for Aarey Drugs & Pharmaceuticals Ltd reflects persistent selling pressure with no immediate demand to absorb supply. The falling delivery volumes suggest speculative short-selling rather than outright capitulation, but the liquidity constraints inherent in a micro-cap stock amplify the exit risk for holders. The stock’s position below its short-term moving average confirms a fragile technical state, while the narrow intraday range near the circuit floor indicates sellers dominated throughout the session. This combination of factors raises the question of whether the stock is nearing oversold territory or if the selling pressure has further to run — is this capitulation or just the beginning for Aarey Drugs & Pharmaceuticals Ltd?

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today